MSD, AZ partner LaNova bought by Sino Biopharm for $951m LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million

In a case of consolidation in the #Chinesepharma sector, #LaNovaMedicines is being bought out by minority shareholder #SinoBiopharm in a deal valued at around $951 million.

pharmaphorum.com/news/msd-az-...